XE
Xenon Pharmaceuticals
XENE · NASDAQ
$58.98 -0.10% (-$0.06)
1M -6.71%
Market Cap $5.70B
P/E Ratio -
Div. Yield -
ROE 43.98%
Bulios Fair Price
$41.56
29.5% downside
Trenutna cena
$58.98
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica XENE trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
43 /100
Fair P/B 4.59x
EV/EBITDA N/A
P/S N/A
Growth
0 /100
Declining Book val. growth 6.92%
Rev. growth 7.36%
FCF growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
0 /100
Poor ROE 43.98%
ROA 31.58%
Asset turnover 0.00x
Debt
100 /100
Low Current ratio 21.02x
Debt/Equity 0.01x
Net debt/EBITDA N/A
Stability
77 /100
Stable EPS volatility 17.53%
Profitable years 0
Beta 0.62x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o XENE
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Ian C. Mortimer
Employees
364
Headquarters
Burnaby
Prihajajoči dogodki
02 NOV.
Earnings
Upcoming earnings report